Early scientific strategy Small but seasoned team with 35 years in strategic science and communications, offering integrated support across medical and commercial functions to shape early scientific strategy for emerging compounds and align it with marketed product strategy, presenting a target for pharmaceutical clients seeking end-to-end storytelling.

Science Story capability In-house capability to develop comprehensive Science Story for top thought leaders and adapt messaging for specialists and primary care, creating scalable content programs and cross-channel delivery appealing to pharma brands aiming to boost scientific credibility and audience reach.

Award‑winning credibility Extensive recognition with over 340 major awards in the field, which can be leveraged to pursue opportunities with risk-averse clients seeking proven impact, particularly in competitive bids and RFPs where differentiation matters.

Niche agency fit Small firm size (2-10 employees) indicates agility and personalized service, making Shaw Science appealing to mid- to late-stage biotech and specialty pharma clients seeking bespoke, fast-turnaround science and communications programs.

Digital and medical integration Combined digital capabilities and traditional medical education offerings (advisory boards, publications, MSL training) position them to upsell integrated programs to clients needing both digital engagement and medical education components across multiple channels.